Standard of Care (Investigator Choice) clinical trials

A Novel Extracorporeal Liver Support Therapy In ALCF and to Evaluate the Efficacy of DIALIVE 2.0, a Liver Dialysis Device.

This study is testing a new 'liver dialysis' device called DIALIVE 2.0 for people with serious liver failure. It aims to see if adding this treatment to usual care helps patients more. We're looking for 72 people in the UK with worsening liver cirrhosis to take part.